Amazon aims to turn GLP-1 demand into a funnel for One Medical, though limiting new prescriptions to members softens the competitive threat to other telehealth players.
Microsoft courts AI-era marketers: AI Max and chat-native ad formats aim to capture spend as discovery drifts from keywords to copilots.
Meta’s AI race gets personal: Keystroke tracking feeds agentic AI training but risks trust and hints at a future where staff data powers Big Tech models.
AI adoption hits human wall: 44% of Gen Zers sabotage AI plans despite productivity benefits as job fears outweigh utility and turn adoption into a labor standoff.
GenAI rewrites retail playbooks: As AI traffic jumps 393% YoY and converts 42% better, brands should prioritize machine readability to seize AI visits.
Jet fuel spike forces cuts, raising fares and clouding outlook for travel-driven sales.
YouTube is the top platform for watching creators across every demographic of US children, according to a February report from Precisify.
Energy drink brand Accelerator Active Energy believes their history with athlete creators gives them a competitive edge in connecting with fans.
Pump prices boost overall sales while discretionary categories lose steam.
The company aims to revive traffic and support ecommerce efficiency with upgraded stores.
Apple shows hardware still rules: Choosing Ternus for CEO elevates product development as AI, Siri, and smart devices demand faster answers.
Judicious credit strategy helped the co-brand giant power volume growth as cardholders fell.
Family-oriented services could help Cash App snag longtime users.
Stablecoin-backed solutions are unlocking real-world use cases for gig workers.
AI-driven digital growth supports profitability and efficient scaling in a constrained environment.
Its shift to full-service banking aims to deepen customer relationships.
It aims to become a credit card–only bank for credit-marginalized consumers.
By cutting unprofitable members to restore margins and investing in AI to boost efficiency, UnitedHealth’s strategy offers insurers a 2026 survival guide.
Many self-diagnosers skip seeing a provider—raising the stakes for pharma brands to better connect patients with doctors.